14 payers pledge support for ACCESS model
(By: Elizabeth Casolo for Becker’s Hospital Review) Fourteen health insurers have voluntarily committed to CMS’ “Advancing Chronic Care with Effective,
Read More
CMS
The IRA Has Improved Coverage of Drugs Selected for Medicare Price Negotiation
(Authors: Juliette Cubanski and Nolan Sroczynski for The Kaiser Family Foundation Published: Feb 11, 2026) The Medicare Drug Price Negotiation
Read More10 years after CMS’ first mandatory bundled payment model, what did it actually build?
(By: Jakob Emerson for Becker’s Hospital Review) This April will mark a decade since CMS launched the Comprehensive Care for
Read MoreExamining the Potential Impact of Medicare’s New WISeR Model
(Authors: Alex Cottrill, Jeannie Fuglesten Biniek, Juliette Cubanski, Tricia Neuman, and Misha Segal for The Kaiser Family Foundation Published: Feb
Read More
CMS revives nursing home staffing campaign after scrapping 24-hour rule
(By: Elizabeth Gregerson for Becker’s Hospital Review) CMS has republished a Notice of Funding Opportunity related to addressing nursing home
Read MoreCMS proposes rules to lower healthcare costs
(By: Madeline Ashley for Becker’s Hospital Review) CMS unveiled a Feb. 9 proposal to reshape the federal health insurance marketplace,
Read More
Molina to drop Medicare Advantage prescription drug plans in 2027
(By: Jakob Emerson for Becker’s Hospital Review) Molina Healthcare will exit the Medicare Advantage Part D business in 2027, the
Read More
What experts say individuals should consider before changing Medicare Advantage plans.
We are now past the halfway mark of the 2026 Medicare Advantage open enrollment period. The Medicare Advantage Open Enrollment
Read More
The future of Medicare Advantage plans
When the Centers for Medicare and Medicaid Services (CMS) announced its proposed 0.09 percent increase in Medicare Advantage payments for
Read More
Proposed MA rate will result in ‘higher premiums, reduced benefits, and less coverage options’: Fitch
(By: Jakob Emerson for Becker’s Hospital Review) Medicare Advantage insurers will likely continue to scale back supplemental benefits and exit
Read More